This Lucira COVID-19 All-In-One Test can be performed at home or in a medical office and provide results within 30 minutes. Just order your test, collect your sample, and get your results. This product includes a full results report from Meenta that meets the requirements for travel to the US and Canada.
Meenta is proud to support you as the ONLY virtual testing site approved by the government of Japan for pre-travel COVID-19 testing. Thousands of people are already using this product to compete and attend the competitions in Tokyo, Japan.
The At-Home Lucira Check It provides PCR quality results in 30 minutes or less. This is the new COVID-19 test you can trust for whenever you need it. If you are interested in purchasing more than the maximum allowed number of test kits, please contact firstname.lastname@example.org and she will be able to help you place your order.
The 15-minute BinaxNOW™ COVID-19 Ag Card Home Test is a complete at-home solution to rapid COVID-19 testing. This BinaxNOW COVID test is the first FDA/EUA-authorized, virtually guided, COVID-19 rapid test with automated results reporting. Live testing support from eMed Certified Guides ensures improved sample collection and confidence in results. This product is good to use for international re-entry into the United States.
Are you symptomatic and in need of an ultra-fast COVID-19 test? Instead of waiting days for an answer like some RT-PCR based tests, the Carestart COVID-19 Antigen Test for nasal swabs can yield results in just 15-30 minutes and could be perfect for you.
Infinity Biologics has a simple, saliva-based COVID-19 diagnostic testing solution that is approved for at-home sample collection. This test was the first saliva test to receive authorization, so they have a lot of experience with providing hundreds of thousands of tests with the accuracy of a PCR-based test.
The most cost-efficient way to test a group of people in areas with a low prevalence of COVID-19 is sample pooling. Pooling—sometimes referred to as pool testing or pooled testing—means combining samples from several people and conducting one laboratory test on the combined pool of samples to detect SARS-CoV-2, the virus that causes COVID-19. Mirimus has created a new, high-volume COVID-19 PCR testing product, SalivaClear™, a three-stage surveillance and individual reflex testing strategy to monitor and detect infections in populations by testing people in groups called pools.
The need for a highly accurate test does not mean that you need to provide a nasal swab sample. Leading researchers agree that for RT-PCR-based testing, the use of saliva saliva-based tests can provide an easier collection method while maintaining the high accuracy standards using swab samples. MicroGenDX Laboratories is now one of the world leaders in providing this type of test, allowing you to simplify your sample collection with confidence.
The Ellume COVID-19 Home Test is a type of test called an antigen test. When you have COVID-19, the SARS-CoV-2 virus (the virus that causes COVID-19) can be present in your nasal secretions. The Ellume COVID-19 Home Test can detect small parts of SARS-CoV-2 virus in your nasal secretions. These small parts of the SARS-CoV-2 virus are known as proteins or antigens.
To limit the spread of COVID-19, the Avellino SARS-CoV-2/COVID-19 Test (AvellinoCoV2) provides a mid-turbinate swab test that is less invasive and easy to collect. AvellinoCoV2 was developed by the same lab that performs the test, Avellino Lab USA, Inc., a leader in molecular diagnostics and genetic testing.
The 15-minute BinaxNOW™ COVID-19 Ag Card, a rapid antigen test, was designed alongside the revolutionary NAVICA™ digital system for testing in CLIA-waived settings like universities, offices, pharmacies, long term care facilities.
MicroGenDX is now offering pooled, saliva-based testing as a way for groups to test for COVID-19 on a more regular and affordable basis. Saliva samples are collected and sent to the lab, where they are combined in pools of four and tested for SARS-CoV-2, allowing for more efficient testing strategies, particularly in areas of low COVID-19 incidence.